Crossmark

Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand

Crossref DOI link: https://doi.org/10.1186/s12889-021-12429-6

Published Online: 2022-01-20

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thitipatarakorn, Supanat

Chinbunchorn, Tanat

Peelay, Jitsupa

Seekaew, Pich

Amatavete, Sorawit

Sangsai, Monsiri

Pankam, Tippawan

Avihingsanon, Anchalee

Avery, Matthew

Phanuphak, Praphan

Ramautarsing, Reshmie

Phanuphak, Nittaya
License Information

Text and Data Mining valid from 2022-01-20

Version of Record valid from 2022-01-20
More Information

Article History

Received: 8 June 2021

Accepted: 3 December 2021

First Online: 20 January 2022

Declarations

:

: The Same-Day Antiretroviral Therapy Initiation protocol (NCT04032028) was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University with Approval Number 158/56. Institutional Review Board of the Faculty of Medicine, Chulalongkorn University has waived the informed consent for the study. All methods were carried out in accordance with relevant guidelines and regulations.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below